This study sought to characterize the association between region of residence and cancer centre proximity and the receipt of a pre-treatment medical oncology consultation and NAC for female patients with TN and HER2+ breast cancer in Ontario, Canada, with a view to better understand the receipt of guideline-concordant care and inform efforts to improve it for this patient population. The gene discussed is ERBB2; the disease is breast cancer.